UKTI Logo Sitemap | Help
Text size: a  a  a Home About Us How We Help Contact Us Events Downloads OurWorld  
 
 
My UK
Create email alerts
 
Why the UK?
Key advantages Business factors Investment regions Forming a company Living & leisure
 
Your business sector
Aerospace Automotive Creative industries Environment & renewable energy Financial & Business Services Food & drink ICT Life sciences Nanotechnology More sectors
 
UK advisory network
Welcome to the network Get professional advice Give professional advice Network news & events
OurWorld…passionate about business01-Dec-08
Welcome to UK Trade & Investment today

BioToolomics tests new medical product

A UK firm is to trial a product which could help in the development of new drugs and vaccines.

County Durham-based BioToolomics specialises in bioseparation, or a process which separates chemicals to purify them, and has developed an innovative new product.

The firm's new 'resin technology' chromotography column is claimed to be up to 100 times more efficient than other solutions and can be used to create drugs based on antibodies, vaccines and enzymes.

BioToolomics used an award of £65,000 from the Three Pillar Fund and £140,000 of financing from loans and grants to develop the product.

'

This is a huge advantage for development and production use in the pharmaceutical industry

Dr Chad Zhang

Director and Founder

BioToolomics

'

Dr Chad Zhang, who set up the business two years ago, told the newspaper: "This is a huge advantage for development and production use in the pharmaceutical industry.

He also revealed that the firm, which is based at the Consett Innovation Centre, aims to launch the product onto the market over the next year.

UK’s R&D sector

Read more about the UK’s R&D sector

The Consett Innovation Centre is designed to support start-up ventures and provides them with business and technical support to grow their operations.



How can we help you?

Discover how our global network of business champions can help you achieve your goals.

We have personalised services for foreign investors, consultants, media/press, and students.